Company overview
Basic information
Company name
Nevitra, UAB
Company code
300131230
VAT code
LT100001789711
Registered address
Klaipėda, Geležinkelio g. 20, LT-92261
Registration date
2005-07-19
Company age: 21 y. 3 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Freight transport by road
Ownership form
Private without foreign capital
UAB "Nevitra"
Company code: 300131230
Address: Klaipėda, Geležinkelio g. 20, LT-92261
VAT code: LT100001789711
Description
This description was generated by artificial intelligence.
Nevitra, UAB (company code 300131230) is an operational private limited liability company registered in 2005. It is a privately owned micro company operating in the national private non-financial companies sector, with governance described as CEO only. The company is based in Klaipeda, Geležinkelio g. 20, Klaipedos m. sav., Klaipedos apskr. Its main activity is freight transport by road (EVRK code H.49.41.00). The company’s share capital is €2.9K.
In financial year 2025, Nevitra generated revenue of €76.1K, up 2.8% year on year and 5.5% over two years. Net profit was €1.4K, with a profit margin of 1.9%. The company reported equity of €13.6K, liabilities of €79.3K and total assets of €92.9K. Financial results show a strong deterioration in 2024, when the company posted a net loss of €55.0K, followed by a return to profit in 2025.
The company has remained very small in staffing terms, with an average of 1 employee in 2023, 2024 and 2025, and 1 employee on average so far in 2026.
In financial year 2025, Nevitra generated revenue of €76.1K, up 2.8% year on year and 5.5% over two years. Net profit was €1.4K, with a profit margin of 1.9%. The company reported equity of €13.6K, liabilities of €79.3K and total assets of €92.9K. Financial results show a strong deterioration in 2024, when the company posted a net loss of €55.0K, followed by a return to profit in 2025.
The company has remained very small in staffing terms, with an average of 1 employee in 2023, 2024 and 2025, and 1 employee on average so far in 2026.
Download a detailed company report
Make confident decisions with all the information about Nevitra, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.